The findings of this study showed that treatment with CHA in glioma-bearing mice inhibited the distribution of M2 type macrophages (F4/80+/CD206+ double labeled cells), consistent with the reduction of tumor weight observed in these mice. This evidence concerns the gene MRC1 and central nervous system cancer.